Quarterly ResultMay 11, 2026, 06:27 AM
Certara Q1 Revenue $106.9M; Net Loss $8.8M; Divests Medical Writing Business
AI Summary
Certara reported first quarter 2026 financial results, with total revenue increasing 1% to $106.9 million, but a net loss of $8.8 million compared to a net income in the prior year. The company completed the divestiture of its global medical writing and related regulatory services business for $85.0 million cash, with potential additional consideration. This strategic move aims to sharpen execution and position Certara for long-term growth, with updated 2026 guidance reflecting the divestiture.
Key Highlights
- Certara divested its Medical Writing business for $85.0M cash, plus $15.0M in escrow and up to $35.0M earn-out.
- Total revenue grew 1% to $106.9 million in Q1 2026.
- Software revenue increased 7% to $49.7 million; Services revenue decreased 4% to $57.2 million.
- Net loss was $8.8 million, a 285% decrease from net income of $4.7 million in Q1 2025.
- Adjusted EBITDA decreased 9% to $31.7 million.
- Diluted loss per share was $0.06, compared to diluted EPS of $0.03 in Q1 2025.
- Total bookings decreased 2% to $115.3 million, with software bookings up 20% to $48.7 million.
- Updated 2026 revenue guidance is $395M-$405M, with 0%-4% growth excluding the divested business.
Price Impact
More from CERT